Search

Author/Creator Kivitz, A J

1. A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. Issue 1 (8th July 2004)

Authors:
van Holten, J; Pavelka, K; Vencovsky, J; Stahl, H; Rozman, B; Genovese, M; Kivitz, A J; Alvaro, J; Nuki, G; Furst, D E; Herrero-Beaumont, G; McInnes, I B; Musikic, P; Tak, P P
Journal:
Annals of the rheumatic diseases
Issue:
Volume 64:Issue 1(2005)
Page Start:
64
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial. Issue 6 (13th August 2008)

Authors:
van der Heijde, D; Schiff, M H; Sieper, J; Kivitz, A J; Wong, R L; Kupper, H; Dijkmans, B A C; Mease, P J; Davis, J C
Journal:
Annals of the rheumatic diseases
Issue:
Volume 68:Issue 6(2009)
Page Start:
922
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study. (July 2017)

Authors:
Burge, D J; Eisenman, J; Byrnes-Blake, K; Smolak, P; Lau, K; Cohen, S B; Kivitz, A J; Levin, R; Martin, R W; Sherrer, Y; Posada, J A
Journal:
Lupus
Issue:
Volume 26:Number 8(2017)
Page Start:
825
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗